More on ELVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Enliven Therapeutics, Inc (NQ:ELVN)
Delayed: 41.52 -0.41 (0.98%)
Prev. Close $41.93  
Open$41.49 
52 Wk High$ 
52 Wk Low$ 
Day High$41.64 
Day Low$40.82 
P/E N/A  
EPS$ 
Volume2,298,506 

Friends, Peers and Foes (?): ALLO, CHRS, ONCY, PYXS, MAZE (more...)

Oct 21, 2026 05:54 PM Form 4 Enliven Therapeutics, For: Oct 19 Filed by: Hohl Benjamin
Oct 21, 2026 05:52 PM Form 4 Enliven Therapeutics, For: Oct 19 Filed by: Collins Helen Louise
Oct 19, 2026 04:17 PM Form 144 Enliven Therapeutics, Filed by: Collins Helen Louise
Oct 19, 2026 07:54 AM Enliven Therapeutics (ELVN) PT Raised to $73 at H.C. Wainwright
Oct 16, 2026 04:43 PM Form 4 Enliven Therapeutics, For: Oct 14 Filed by: BALL KRISTINE M
Oct 16, 2026 04:41 PM Form 3 Enliven Therapeutics, For: Oct 14 Filed by: BALL KRISTINE M
Oct 14, 2026 04:39 PM Form 8-K Enliven Therapeutics, For: Oct 14
Oct 14, 2026 04:30 PM Enliven Therapeutics adds Kristine Ball to its board of directors
Oct 14, 2026 04:30 PM Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year
Oct 8, 2026 06:55 AM Guggenheim Reiterates Buy Rating on Enliven Therapeutics (ELVN)
View All Articles

Entities mentioned with ELVN

View All Entities